Value assessment frameworks in oncology: championing concordance through shared standards
Authors:
- 1 April 2019
- journal article
- editorial
- Published by Elsevier in Annals of Oncology
- Vol. 30 (4) , 505-506
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Comparative Assessment of Clinical Benefit Using the ESMO-Magnitude of Clinical Benefit Scale Version 1.1 and the ASCO Value Framework Net Health Benefit ScoreJournal of Clinical Oncology, 2019
- Examining Trends in Cost and Clinical Benefit of Novel Anticancer Drugs Over TimeJournal of Oncology Practice, 2018
- ESMO-Magnitude of Clinical Benefit Scale version 1.1Annals of Oncology, 2017
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016JAMA Oncology, 2017
- Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments ReceivedJournal of Clinical Oncology, 2016